Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
REMS
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
*COVID-19 Pharmacy Resources
Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
REMS
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Search results for:
tranexamic acid
tranexamic acid
Brand names:
Cyklokapron
Form
Strength
ANAN
ASMP
LACH
LALK
LOHH
LOLR
LOWC
SDSD
SESE
SFSF
Formulary Status
SOLUTION, INTRAVENOUS
10 mg/mL-NaCl 0.7%; 100 mg/mL
TABLET, ORAL
650 mg
VIEW MORE
Hemostatics
CLASS
202816
Comments:
Screen for contraindications to TXA use prior to administration
hypersensitivity to TXA
Active thromboembolic disease
History of thrombosis or thromboembolism
Intrinsic risk of thrombosis
Last updated:
Nov. 30, 2021
UpToDate
FDA Package Inserts
Acadiana Market Specific P&T Updates
Jackson Market Specific P&T Updates
UpToDate Lexidrug
Screen for contraindications to TXA use prior to administration